                         SEQUENCE LISTING

<110>  Board of Regents, The University of Texas System
 
<120>  HLA RESTRICTED HORMAD1 T CELL RECEPTORS AND USES THEREOF

<130>  UTSC.P1238WO

<140>  
<141>  2020-11-05

<150>  62/930,892
<151>  2019-11-05

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  804
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
atgaggcaag tggcgagagt gatcgtgttc ctgaccctga gtactttgag ccttgctaag       60

accacccagc ccatctccat ggactcatat gaaggacaag aagtgaacat aacctgtagc      120

cacaacaaca ttgctacaaa tgattatatc acgtggtacc aacagtttcc cagccaagga      180

ccacgattta ttattcaagg atacaagaca aaagttacaa acgaagtggc ctccctgttt      240

atccctgccg acagaaagtc cagcactctg agcctgcccc gggtttccct gagcgacact      300

gctgtgtact actgcctcgt gggtgcgcgg ggaactgctc tgatctttgg gaagggaacc      360

accttatcag tgagttccaa tatccagaac cctgaccctg ccgtgtacca gctgagagac      420

tctaaatcca gtgacaagtc tgtctgccta ttcaccgatt ttgattctca aacaaatgtg      480

tcacaaagta aggattctga tgtgtatatc acagacaaaa ctgtgctaga catgaggtct      540

atggacttca agagcaacag tgctgtggcc tggagcaaca aatctgactt tgcatgtgca      600

aacgccttca acaacagcat tattccagaa gacaccttct tccccagccc agaaagttcc      660

tgtgatgtca agctggtcga gaaaagcttt gaaacagata cgaacctaaa ctttcaaaac      720

ctgtcagtga ttgggttccg aatcctcctc ctgaaagtgg ccgggtttaa tctgctcatg      780

acgctgcggc tgtggtccag ctaa                                             804


<210>  2
<211>  267
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  2

Met Arg Gln Val Ala Arg Val Ile Val Phe Leu Thr Leu Ser Thr Leu 
1               5                   10                  15      


Ser Leu Ala Lys Thr Thr Gln Pro Ile Ser Met Asp Ser Tyr Glu Gly 
            20                  25                  30          


Gln Glu Val Asn Ile Thr Cys Ser His Asn Asn Ile Ala Thr Asn Asp 
        35                  40                  45              


Tyr Ile Thr Trp Tyr Gln Gln Phe Pro Ser Gln Gly Pro Arg Phe Ile 
    50                  55                  60                  


Ile Gln Gly Tyr Lys Thr Lys Val Thr Asn Glu Val Ala Ser Leu Phe 
65                  70                  75                  80  


Ile Pro Ala Asp Arg Lys Ser Ser Thr Leu Ser Leu Pro Arg Val Ser 
                85                  90                  95      


Leu Ser Asp Thr Ala Val Tyr Tyr Cys Leu Val Gly Ala Arg Gly Thr 
            100                 105                 110         


Ala Leu Ile Phe Gly Lys Gly Thr Thr Leu Ser Val Ser Ser Asn Ile 
        115                 120                 125             


Gln Asn Pro Asp Pro Ala Val Tyr Gln Leu Arg Asp Ser Lys Ser Ser 
    130                 135                 140                 


Asp Lys Ser Val Cys Leu Phe Thr Asp Phe Asp Ser Gln Thr Asn Val 
145                 150                 155                 160 


Ser Gln Ser Lys Asp Ser Asp Val Tyr Ile Thr Asp Lys Thr Val Leu 
                165                 170                 175     


Asp Met Arg Ser Met Asp Phe Lys Ser Asn Ser Ala Val Ala Trp Ser 
            180                 185                 190         


Asn Lys Ser Asp Phe Ala Cys Ala Asn Ala Phe Asn Asn Ser Ile Ile 
        195                 200                 205             


Pro Glu Asp Thr Phe Phe Pro Ser Pro Glu Ser Ser Cys Asp Val Lys 
    210                 215                 220                 


Leu Val Glu Lys Ser Phe Glu Thr Asp Thr Asn Leu Asn Phe Gln Asn 
225                 230                 235                 240 


Leu Ser Val Ile Gly Phe Arg Ile Leu Leu Leu Lys Val Ala Gly Phe 
                245                 250                 255     


Asn Leu Leu Met Thr Leu Arg Leu Trp Ser Ser 
            260                 265         


<210>  3
<211>  963
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  3
atgcttagtc ctgacctgcc tgactctgcc tggaacacca ggctcctctg ccatgtcatg       60

ctttgtctcc tgggagcagg ttcagtggct gctggagtca tccagtcccc aagacatctg      120

atcaaagaaa agagggaaac agccactctg aaatgctatc ctatccctag acacgacact      180

gtctactggt accagcaggg tccaggtcag gacccccagt tcctcatttc gttttatgaa      240

aagatgcaga gcgataaagg aagcatccct gatcgattct cagctcaaca gttcagtgac      300

tatcattctg aactgaacat gagctccttg gagctggggg actcagccct gtacttctgt      360

gccagcagcc ctacgggaca gggttcgtac gagcagtact tcgggccggg caccaggctc      420

acggtcacag aggacctgaa aaacgtgttc ccacccgagg tcgctgtgtt tgagccatca      480

gaagcagaga tctcccacac ccaaaaggcc acactggtgt gcctggccac aggcttcttc      540

cctgaccacg tggagctgag ctggtgggtg aatgggaagg aggtgcacag tggggtcagc      600

acggacccgc agcccctcaa ggagcagccc gccctcaatg actccagata ctgcctgagc      660

agccgcctga gggtctcggc caccttctgg cagaaccccc gcaaccactt ccgctgtcaa      720

gtccagttct acgggctctc ggagaatgac gagtggaccc aggatagggc caaacccgtc      780

acccagatcg tcagcgccga ggcctggggt agagcagact gtggctttac ctcggtgtcc      840

taccagcaag gggtcctgtc tgccaccatc ctctatgaga tcctgctagg gaaggccacc      900

ctgtatgctg tgctggtcag cgcccttgtg ttgatggcca tggtcaagag aaaggatttc      960

taa                                                                    963


<210>  4
<211>  320
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  4

Met Leu Ser Pro Asp Leu Pro Asp Ser Ala Trp Asn Thr Arg Leu Leu 
1               5                   10                  15      


Cys His Val Met Leu Cys Leu Leu Gly Ala Gly Ser Val Ala Ala Gly 
            20                  25                  30          


Val Ile Gln Ser Pro Arg His Leu Ile Lys Glu Lys Arg Glu Thr Ala 
        35                  40                  45              


Thr Leu Lys Cys Tyr Pro Ile Pro Arg His Asp Thr Val Tyr Trp Tyr 
    50                  55                  60                  


Gln Gln Gly Pro Gly Gln Asp Pro Gln Phe Leu Ile Ser Phe Tyr Glu 
65                  70                  75                  80  


Lys Met Gln Ser Asp Lys Gly Ser Ile Pro Asp Arg Phe Ser Ala Gln 
                85                  90                  95      


Gln Phe Ser Asp Tyr His Ser Glu Leu Asn Met Ser Ser Leu Glu Leu 
            100                 105                 110         


Gly Asp Ser Ala Leu Tyr Phe Cys Ala Ser Ser Pro Thr Gly Gln Gly 
        115                 120                 125             


Ser Tyr Glu Gln Tyr Phe Gly Pro Gly Thr Arg Leu Thr Val Thr Glu 
    130                 135                 140                 


Asp Leu Lys Asn Val Phe Pro Pro Glu Val Ala Val Phe Glu Pro Ser 
145                 150                 155                 160 


Glu Ala Glu Ile Ser His Thr Gln Lys Ala Thr Leu Val Cys Leu Ala 
                165                 170                 175     


Thr Gly Phe Phe Pro Asp His Val Glu Leu Ser Trp Trp Val Asn Gly 
            180                 185                 190         


Lys Glu Val His Ser Gly Val Ser Thr Asp Pro Gln Pro Leu Lys Glu 
        195                 200                 205             


Gln Pro Ala Leu Asn Asp Ser Arg Tyr Cys Leu Ser Ser Arg Leu Arg 
    210                 215                 220                 


Val Ser Ala Thr Phe Trp Gln Asn Pro Arg Asn His Phe Arg Cys Gln 
225                 230                 235                 240 


Val Gln Phe Tyr Gly Leu Ser Glu Asn Asp Glu Trp Thr Gln Asp Arg 
                245                 250                 255     


Ala Lys Pro Val Thr Gln Ile Val Ser Ala Glu Ala Trp Gly Arg Ala 
            260                 265                 270         


Asp Cys Gly Phe Thr Ser Val Ser Tyr Gln Gln Gly Val Leu Ser Ala 
        275                 280                 285             


Thr Ile Leu Tyr Glu Ile Leu Leu Gly Lys Ala Thr Leu Tyr Ala Val 
    290                 295                 300                 


Leu Val Ser Ala Leu Val Leu Met Ala Met Val Lys Arg Lys Asp Phe 
305                 310                 315                 320 


<210>  5
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  5

Tyr Leu Asp Asp Leu Cys Val Lys Ile 
1               5                   


<210>  6
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  6

Asn Ile Ala Thr Asn Asp Tyr 
1               5           


<210>  7
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  7

Gly Tyr Lys Thr Lys 
1               5   


<210>  8
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  8

Leu Val Gly Ala Arg Gly Thr Ala Leu Ile Phe 
1               5                   10      


<210>  9
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  9

Pro Arg His Asp Thr 
1               5   


<210>  10
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  10

Phe Tyr Glu Lys Met Gln 
1               5       


<210>  11
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  11

Ala Ser Ser Pro Thr Gly Gln Gly Ser Tyr Glu Gln Tyr 
1               5                   10              


<210>  12
<211>  330
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  12
cttgctaaga ccacccagcc catctccatg gactcatatg aaggacaaga agtgaacata       60

acctgtagcc acaacaacat tgctacaaat gattatatca cgtggtacca acagtttccc      120

agccaaggac cacgatttat tattcaagga tacaagacaa aagttacaaa cgaagtggcc      180

tccctgttta tccctgccga cagaaagtcc agcactctga gcctgccccg ggtttccctg      240

agcgacactg ctgtgtacta ctgcctcgtg ggtgcgcggg gaactgctct gatctttggg      300

aagggaacca ccttatcagt gagttccaat                                       330


<210>  13
<211>  110
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  13

Leu Ala Lys Thr Thr Gln Pro Ile Ser Met Asp Ser Tyr Glu Gly Gln 
1               5                   10                  15      


Glu Val Asn Ile Thr Cys Ser His Asn Asn Ile Ala Thr Asn Asp Tyr 
            20                  25                  30          


Ile Thr Trp Tyr Gln Gln Phe Pro Ser Gln Gly Pro Arg Phe Ile Ile 
        35                  40                  45              


Gln Gly Tyr Lys Thr Lys Val Thr Asn Glu Val Ala Ser Leu Phe Ile 
    50                  55                  60                  


Pro Ala Asp Arg Lys Ser Ser Thr Leu Ser Leu Pro Arg Val Ser Leu 
65                  70                  75                  80  


Ser Asp Thr Ala Val Tyr Tyr Cys Leu Val Gly Ala Arg Gly Thr Ala 
                85                  90                  95      


Leu Ile Phe Gly Lys Gly Thr Thr Leu Ser Val Ser Ser Asn 
            100                 105                 110 


<210>  14
<211>  342
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  14
gctgctggag tcatccagtc cccaagacat ctgatcaaag aaaagaggga aacagccact       60

ctgaaatgct atcctatccc tagacacgac actgtctact ggtaccagca gggtccaggt      120

caggaccccc agttcctcat ttcgttttat gaaaagatgc agagcgataa aggaagcatc      180

cctgatcgat tctcagctca acagttcagt gactatcatt ctgaactgaa catgagctcc      240

ttggagctgg gggactcagc cctgtacttc tgtgccagca gccctacggg acagggttcg      300

tacgagcagt acttcgggcc gggcaccagg ctcacggtca ca                         342


<210>  15
<211>  114
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  15

Ala Ala Gly Val Ile Gln Ser Pro Arg His Leu Ile Lys Glu Lys Arg 
1               5                   10                  15      


Glu Thr Ala Thr Leu Lys Cys Tyr Pro Ile Pro Arg His Asp Thr Val 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Gly Pro Gly Gln Asp Pro Gln Phe Leu Ile Ser 
        35                  40                  45              


Phe Tyr Glu Lys Met Gln Ser Asp Lys Gly Ser Ile Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Gln Gln Phe Ser Asp Tyr His Ser Glu Leu Asn Met Ser Ser 
65                  70                  75                  80  


Leu Glu Leu Gly Asp Ser Ala Leu Tyr Phe Cys Ala Ser Ser Pro Thr 
                85                  90                  95      


Gly Gln Gly Ser Tyr Glu Gln Tyr Phe Gly Pro Gly Thr Arg Leu Thr 
            100                 105                 110         


Val Thr 
        


